{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:29:22Z","timestamp":1784204962851,"version":"3.55.0"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n            <jats:title>Objective\u2014<\/jats:title>\n            <jats:p>Abdominal aortic aneurysm (AAA) is a permanent dilation of the abdominal aorta associated with rupture, which frequently results in fatal consequences. AAA tissue is commonly characterized by localized structural deterioration accompanied with inflammation and profound accumulation of leukocytes, although the specific function of these cells is unknown. Cilostazol, a phosphodiesterase III inhibitor, is commonly used for patients with peripheral vascular disease or stroke because of its anti-platelet aggregation effect and anti-inflammatory effect, which is vasoprotective effect. In this study, we evaluated the effects of cilostazol on angiotensin II\u2013induced AAA formation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Results\u2014<\/jats:title>\n            <jats:p>Male apolipoprotein E\u2013deficient mice were fed either normal diet or a diet containing cilostazol (0.1% wt\/wt). After 1 week of diet consumption, mice were infused with angiotensin II (1000 ng\/kg per minute) for 4 weeks. Angiotensin II infusion increased maximal diameters of abdominal aortas, whereas cilostazol administration significantly attenuated dilatation of abdominal aortas, thereby, reducing AAA incidence. Cilostazol also reduced macrophage accumulation, matrix metalloproteinases activation, and inflammatory gene expression in the aortic media. In cultured vascular endothelial cells, cilostazol reduced expression of inflammatory cytokines and adhesive molecules through activation of the cAMP\u2013PKA (protein kinase A) pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>Cilostazol attenuated angiotensin II\u2013induced AAA formation by its anti-inflammatory effect through phosphodiesterase III inhibition in the aortic wall. Cilostazol may be a promising new therapeutic option for AAAs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/atvbaha.117.309707","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T15:35:54Z","timestamp":1518536154000},"page":"903-912","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Cilostazol Attenuates Angiotensin II\u2013Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E\u2013Deficient Mice"],"prefix":"10.1161","volume":"38","author":[{"given":"Ryoko","family":"Umebayashi","sequence":"first","affiliation":[{"name":"From the Department of Nephrology, Rheumatology, Endocrinology and Metabolism (R.U., H.A.U., Y.K., J.W.) and Department of Chronic Kidney Disease and Cardiovascular Disease (H.A.U.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan; and Saha Cardiovascular Research Center (V.S., A.D.) and Department of Physiology (V.S., A.D.), University of Kentucky, Lexington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhito A.","family":"Uchida","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology, Rheumatology, Endocrinology and Metabolism (R.U., H.A.U., Y.K., J.W.) and Department of Chronic Kidney Disease and Cardiovascular Disease (H.A.U.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan; and Saha Cardiovascular Research Center (V.S., A.D.) and Department of Physiology (V.S., A.D.), University of Kentucky, Lexington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kakio","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology, Rheumatology, Endocrinology and Metabolism (R.U., H.A.U., Y.K., J.W.) and Department of Chronic Kidney Disease and Cardiovascular Disease (H.A.U.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan; and Saha Cardiovascular Research Center (V.S., A.D.) and Department of Physiology (V.S., A.D.), University of Kentucky, Lexington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateswaran","family":"Subramanian","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology, Rheumatology, Endocrinology and Metabolism (R.U., H.A.U., Y.K., J.W.) and Department of Chronic Kidney Disease and Cardiovascular Disease (H.A.U.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan; and Saha Cardiovascular Research Center (V.S., A.D.) and Department of Physiology (V.S., A.D.), University of Kentucky, Lexington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Daugherty","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology, Rheumatology, Endocrinology and Metabolism (R.U., H.A.U., Y.K., J.W.) and Department of Chronic Kidney Disease and Cardiovascular Disease (H.A.U.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan; and Saha Cardiovascular Research Center (V.S., A.D.) and Department of Physiology (V.S., A.D.), University of Kentucky, Lexington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology, Rheumatology, Endocrinology and Metabolism (R.U., H.A.U., Y.K., J.W.) and Department of Chronic Kidney Disease and Cardiovascular Disease (H.A.U.), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan; and Saha Cardiovascular Research Center (V.S., A.D.) and Department of Physiology (V.S., A.D.), University of Kentucky, Lexington."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66459-8"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2005.03.009"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2012.06.021"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.8707"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta17410"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2015.1074861"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000085631.76095.64"},{"key":"e_1_3_4_9_2","first-page":"1199","article-title":"Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.","volume":"137","author":"Koch AE","year":"1990","unstructured":"Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol. 1990;137:1199\u20131213.","journal-title":"Am J Pathol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.11.2843"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.7.1695"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000118013.72016.ea"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7818"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06332.x"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.10.015"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.731398"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18141"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000143384.69170.2d"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303763"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20140696"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20130660"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.004853"},{"key":"e_1_3_4_23_2","first-page":"38","article-title":"Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.","volume":"232","author":"Cheng J","year":"2007","unstructured":"Cheng J, Grande JP. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med (Maywood). 2007;232:38\u201351.","journal-title":"Exp Biol Med (Maywood)"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1540\/jsmr.39.67"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0828-282X(06)70987-4"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2002.0040s2s14.x"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2011.15.4.203"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.101444"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21388"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000117403.64398.53"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309524"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3791\/53191"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3791\/1291"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATV.0000000000000062"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e3182317196"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.234997"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.02.034"},{"key":"e_1_3_4_38_2","first-page":"293","article-title":"Quantification of atherosclerosis in mice.","volume":"209","author":"Daugherty A","year":"2003","unstructured":"Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. Methods Mol Biol. 2003;209:293\u2013309.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307285"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072214"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-571-8_4"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.07.016"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.1.75"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.106.132282"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979086"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.2.709"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00431-2"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2011.01.017"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701124"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01258-9"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.2000.1211"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2006.11.001"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125003143"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2006.03.026"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8931"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.06.036"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.08.023"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-015-0030-1"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.079780"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296604"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B1101002"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133279.07468.9F"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.2000.1262"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.305482"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.192609"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-14-0471"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000388"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90555-5"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(89)90197-2"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050868"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.09.057"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570161111311030005"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.115.305537"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/ATVBAHA.117.309707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T13:50:47Z","timestamp":1732110647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/ATVBAHA.117.309707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1161\/ATVBAHA.117.309707"],"URL":"https:\/\/doi.org\/10.1161\/atvbaha.117.309707","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"2017-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}